Patent ID: 7704951

Claim:
A method of treating dyskinesia, said method comprising the step of administering to a subject in need thereof an effective amount of a medicament comprising a heparin sepharose-binding fraction from plasma precipitated with 2 M ammonium sulfate (Preparation 1), wherein Preparation 1 possesses a cytotoxic-inhibitory activity, and wherein selenocysteine is an amino acid present in Preparation 1 wherein the dyskinesia is associated with a disease or condition selected from the group consisting of: a) a cerebrovascular disorder selected from the group consisting of Binswanger type leukoencephalopathy, chronic subdural hematoma, and angiopathy; b) an autoimmune disease; c) a traumatic disorder selected from the group consisting of a traumatic injury of the spinal cord and a cerebral disorder due to a traffic accident; d) spinocerebellar degeneration; e) Shy-Drager syndrome; f) Machado-Joseph disease; g) myotonic dystrophy; h) Friedrich's ataxia; i) amyotrophic lateral sclerosis; j) Pick disease; k) Huntington chorea; l) progressive supranuclear palsy; and m) epilepsy.